NEW YORK (GenomeWeb) – The National Institutes of Health has awarded an approximately $2.8 million Phase IIB Small Business Innovation Research (SBIR) grant to microRNA diagnostics firm DiamiR.

The three-year grant from the National Institute on Aging will help the company develop its first test, CogniMir, CEO Kira Sheinerman said in a statement. The test is targeted at early-stage Alzheimer's disease patients.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Aug
27
Sponsored by
Qiagen

This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.

Sep
17
Sponsored by
SeraCare

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.

Sep
18
Sponsored by
Horizon Discovery

In this webinar, Kevin Balbi, head of bioinformatics at Sarah Cannon Molecular Diagnostics, will discuss the validation of targeted sequencing panels on the Ion Torrent platform using Horizon Discovery’s Tru-Q controls.